Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Zugna

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
British Journal of Cancer|March 1, 2014
Comment on 'The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)'D Mirabelli, D Zugna
The British Journal of Dermatology|May 5, 2020
Natural history of naevi: a two-wave studyS Ribero, D Zugna, T Spector, et al.
Journal of Developmental Origins of Health and Disease|August 17, 2018
Sources of confounding in life course epidemiologyS Santos, D Zugna, C Pizzi, et al.
BMC Medical Research Methodology|November 24, 2022
Applied causal inference methods for sequential mediatorsD Zugna, M Popovic, F Fasanelli, et al.
The British Journal of Dermatology|October 20, 2015
Prediction of high naevus count in a healthy U.K. population to estimate melanoma riskS Ribero, D Zugna, S Osella-Abate, et al.
Andrology|March 5, 2016
Baldness and testicular cancer: the EPSAM case-control studyG Moirano, D Zugna, C Grasso, et al.
Prostate Cancer and Prostatic Diseases|November 12, 2014
Global DNA hypomethylation in prostate cancer development and progression: a systematic reviewR Zelic, V Fiano, C Grasso, et al.
Epidemiology and Psychiatric Sciences|April 19, 2018
Maternal anxiety, depression and sleep disorders before and during pregnancy, and preschool ADHD symptoms in the NINFEA birth cohort studyL Vizzini, M Popovic, D Zugna, et al.
The Pharmacogenomics Journal|November 9, 2018
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?A Calcagno, M Fiumanò, D Zugna, et al.
British Journal of Cancer|November 11, 2017
Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patientsD Zugna, R Senetta, S Osella-Abate, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Journal of Cancer|March 1, 2014
Comment on 'The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)'D Mirabelli, D Zugna
The British Journal of Dermatology|May 5, 2020
Natural history of naevi: a two-wave studyS Ribero, D Zugna, T Spector, et al.
Journal of Developmental Origins of Health and Disease|August 17, 2018
Sources of confounding in life course epidemiologyS Santos, D Zugna, C Pizzi, et al.
BMC Medical Research Methodology|November 24, 2022
Applied causal inference methods for sequential mediatorsD Zugna, M Popovic, F Fasanelli, et al.
The British Journal of Dermatology|October 20, 2015
Prediction of high naevus count in a healthy U.K. population to estimate melanoma riskS Ribero, D Zugna, S Osella-Abate, et al.
Andrology|March 5, 2016
Baldness and testicular cancer: the EPSAM case-control studyG Moirano, D Zugna, C Grasso, et al.
Prostate Cancer and Prostatic Diseases|November 12, 2014
Global DNA hypomethylation in prostate cancer development and progression: a systematic reviewR Zelic, V Fiano, C Grasso, et al.
Epidemiology and Psychiatric Sciences|April 19, 2018
Maternal anxiety, depression and sleep disorders before and during pregnancy, and preschool ADHD symptoms in the NINFEA birth cohort studyL Vizzini, M Popovic, D Zugna, et al.
The Pharmacogenomics Journal|November 9, 2018
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?A Calcagno, M Fiumanò, D Zugna, et al.
British Journal of Cancer|November 11, 2017
Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patientsD Zugna, R Senetta, S Osella-Abate, et al.
Pageof 2